Our Strengths

EUROCORD has established an international cord blood transplantation registry, which led to major advances in the field. The database and the expertise in performing retrospective and prospective studies have allowed crucial developments in clinical use of cord blood cells.

EUROCORD collaborates with Netcord banks by validation of data and sending statistical analysis of the transplants performeld with their respective units. Eurocord registry based analysis has developed standards,  criteria for donor selection and protocols for umbilical cord blood transplantation, as well as determined prognostic factors for main outcomes, 

EUROCORD has experience in electronic data exchange, statistical analyses, electronic communication with worldwide transplant centers and cord blood banks. The database and the expertise in performing retrospective and prospective studies have allowed crucial developments in clinical use of cord blood cells. Eurocord is involved in new protocols for using cord blood or placenta in the new non-hematological indications.
EUROCORD works on the establishment of non-profit family cord blood banking including hemoglobinopathies, hereditary hematological and immunological disorders as well as non-hematological diseases.

More recently, EUROCORD initiated and lead the project for establishing the “International Sickle Cell Disease Observatory”.
EUROCORD has strong relation with many international organizations including the European Blood and Marrow Transplant (EBMT), World Bone Marrow Transplant (WBMT), Netcord, Center for International Blood and  Marrow Transplant (CIBMTR), National Bone Marrow Donor Program (NMDP), and the World Marrow Donor Association (WMDA).

Words of president
- Eliane Gluckman -

Major improvement has been observed in the field of hematopoietic stem cell...
Read more


Eurocord Monaco

MONACORD is a clinical research organisation, which has established at the Centre Scientifique de Monaco

Read more